Can Nucala cause weight gain?

Drugs.com

Official answer

by Drugs.com

No, weight gain has not been reported as a side effect of Nucala during clinical trials. Corticosteroids such as betamethasone, budesonide, or prednisone, are known to cause weight gain. However, Nucala is not a corticosteroid, it is a biologic that works by binding to cytokines that are small secreted proteins that are involved in cell signaling and interactions.

However, anecdotally, some people have reported a small amount of weight gain on blog sites, although equally as many people report weight loss as well, usually because they no longer need to take as much prednisone.

If you do think you are gaining weight on Nucala, keep a diary that documents your daily diet, amount of exercise, and daily weight gain. Try to eat a healthy diet and exercise regularly. If there is a clear pattern of weight gain, talk with your doctor.

The most common side effects reported with Nucala were:

  • Headaches
  • Injection site reactions (redness, pain, itching, or swelling at the injection site)
  • Back pain
  • Tiredness.

    • Rarely, allergic reactions may occur with Nucala and it may precipitate Shingles.

    Nucala (mepolizumab) is approved:

  • As an add-on maintenance treatment for severe eosinophilic asthma in adults and children aged 6 and older. This is a subtype of asthma that is characterized by high numbers of eosinophils in the blood. Eosinophils are a type of white blood cell and this type of asthma affects 5% of all asthmatics
  • For the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
  • For the treatment of patients ≥12 years with hypereosinophilic syndrome (HES)
  • As an add-on maintenance treatment of chronic rhinosinusitis with nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.

    • Nucala is also approved for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) and for the treatment of patients ≥12 years with hypereosinophilic syndrome (HES).

    Related medical questions

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords